IP Library › Assignment 035475/0336
Patent Assignment
Reel/Frame 035475/0336

Release of Patent Security Interest

Recorded: 2015-04-21 Pages: 5
Assignor
Assignees
COVIS PHARMA S.A.R.L.
33, RUE DU PUITS ROMAIN, L-8070 BERTRANGE, GRAND DUCHY OF, LUXEMBOURG
COVIS PHARMA HOLDINGS S.A.R. L.
33, RUE DU PUITS ROMAIN, L-8070 BERTRANGE, GRAND DUCHY OF, LUXEMBOURG
Covered Properties (14)
Transdermal Pharmaceutical Composition
Patent: 5,523,094 →
Application: 08/277,971 →
Use of 2-Amino-6-(Trifluoromethoxy)Benzothiazole for Obtaining a Medicament for the Treatment of Amyotrophic Lateral Sclerosis
Patent: 5,527,814 →
Application: 08/327,343 →
Alfuzosin Hydrochloride Dihydrate
Patent: 5,545,738 →
Application: 08/364,180 →
Use of Riluzole for the Treatment of Neuro-Aids
Patent: 5,624,945 →
Application: 08/396,106 →
Sustained-Release Compositions of Alfuzosin Hydrochloride
Patent: 5,589,190 →
Application: 08/406,405 →
Application of Riluzole in the Treatment of Neurological Lesions Associated with Trauma
Patent: 5,830,907 →
Application: 08/424,529 →
Application of Riluzole for Promoting Restoration Following Radiation
Patent: 5,656,647 →
Application: 08/446,733 →
Application of Riluzole in the Treatment of Mitochondrial Diseases
Patent: 5,686,475 →
Application: 08/669,530 →
6-Polyfluoroalkoxy-And 6-Polyfluoroalkyl-2-Aminobenzothiazole Derivatives
Patent: 5,795,903 →
Application: 08/817,744 →
Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction
Patent: 6,245,791 →
Application: 09/631,798 →
Combination of riluzole and of gabapentin and its use as a medicament
Patent: 6,350,768 →
Application: 09/718,543 →
Riluzole and Alpha-Tocopherol Combination
Patent: 6,642,262 →
Application: 09/854,318 →
Publication: US 2002/0019426
Use of Riluzole in the Treating Acoustic Traumas
Patent: 6,660,757 →
Application: 09/882,223 →
Publication: US 2002/0004516
Use of Thiazolobenzoheterocycles for Treating Multiple Sclerosis
Patent: 7,041,661 →
Application: 10/737,634 →
Publication: US 2004/0147504
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →
Assignment of Assignor's Interest Apr 21, 2015
From: COVIS PHARMA S.À.R.L., ZUG BRANCH; COVIS PHARMA HOLDINGS S.À.R.L., ZUG BRANCH; COVIS INJECTABLES S.À.R.L., ZUG BRANCH
To: CONCORDIA PHARMACEUTICALS INC.
Reel/Frame 035461/0959 →
Security Interest Apr 21, 2015
From: CONCORDIA HEALTHCARE CORP.; CONCORDIA PHARMACEUTICALS, INC.; CONCORDIA LABORATORIES INC.; PINNACLE BIOLOGICS, INC.
To: ROYAL BANK OF CANADA
Reel/Frame 035456/0015 →
Security Agreement Oct 22, 2015
From: CONCORDIA PHARMACEUTICALS INC.; CONCORDIA LABORATORIES INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 036926/0751 →
Release of Security Interest Nov 5, 2015
From: ROYAL BANK OF CANADA
To: CONCORDIA HEALTHCARE USA INC.; CONCORDIA HEALTHCARE CORP.; CONCORDIA HEALTHCARE INC.; CONCORDIA LABORATORIES INC.
Reel/Frame 036973/0890 →
Security Interest Oct 14, 2016
From: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 040022/0034 →
Termination and Release of Security Interest in Intellectual Property Recorded at Reel/Frame 040022/0034 Sep 7, 2018
From: U.S. BANK NATIONAL ASSOCIATION
To: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
Reel/Frame 047030/0171 →
Termination and Release of Security Interest in Intellectual Property Recorded at Reel/Frame 036926/0751 Sep 7, 2018
From: GOLDMAN SACHS BANK USA
To: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
Reel/Frame 047030/0156 →
Corrective Assignment to Correct the Incorrect Statement That This Document Serves as an Oath/Declaration Previously Recorded on Reel 047030 Frame 0172. Assignor(S) Hereby Confirms the Termination and Release of Security Interest in Intellectual Property Recorded at Reel/Frame 040022/0034. Oct 30, 2018
From: U.S. BANK NATIONAL ASSOCIATION
To: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
Reel/Frame 047364/0962 →
Corrective Assignment to Correct the Statement of Document Serving as an Oath of Declaration Previously Recorded at Reel: 047030 Frame: 0157. Assignor(S) Hereby Confirms the Termination and Release of Security Interest in Intellectual Property. Oct 30, 2018
From: GOLDMAN SACHS BANK USA
To: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
Reel/Frame 047365/0010 →
Merger Nov 16, 2018
From: COVIS PHARMA S.A R.L.
To: COVIS PHARMA B.V.
Reel/Frame 047523/0420 →
Security Interest Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Security Interest Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
Release of Security Interest Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Security Interest Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Release of Security Interest Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →